Increasing Prevalence of Hepatitis B Infections Coupled with Innovation drugs, Heating the Global Hepatitis B Virus Market

Published: Apr 2022

The global hepatitis B virus market is anticipated to grow at a considerable CAGR of 4.1% during the forecast period (2022-2028). The global hepatitis B virus market is likely to be driven by limited access to hepatitis B treatment and diagnostics in many resource-constrained settings, and the rising prevalence of hepatitis B infections, during the forecast period. As per the information provided by Hepatitis B Foundation approximately 1.5 million people become newly infected each year with this virus. These infections are difficult to identify early on and only become obvious after a few weeks. It is a condition that can start at birth and is primarily caused by blood transfusions, dialysis, and razor sharing in healthcare settings.

Browse the full report description “Global Hepatitis B Virus Market Size, Share & Trends Analysis Report By Type (Acute and Chronic), By Distribution Channel (Online Pharmacies and Offline Pharmacies), and By Treatment (Anti-Viral Drugs, Vaccine, and Immune Modulator Drugs) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/hepatitis-b-virus-market

Additionally, factors such as an increase in injectable drug users, increased awareness, the presence of unmet demand, and the anticipated launch of new medications are expected to drive market expansion. Pediatric combination vaccinations, which protect against several causal agents and thereby give separate immunizations, are becoming increasingly popular on the market. Moreover, the government's expanding efforts to raise public knowledge about the benefits of the hepatitis B vaccine among inhabitants. For instance, on the occasion of World Hepatitis Day 2018, India's Ministry of Health and Family Welfare unveiled the National Viral Hepatitis Control Program, which aims to eradicate HBV infection by 2030.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028

Segment Covered- 

  • By Type
  • By Distribution Channel
  • By Treatment

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- including Merck & Co. Inc., GlaxoSmithKline plc., Sanofi, Dynavax Technologies and LG Chem, and others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Hepatitis B Virus Market Report Segment

By Type

  • Acute
  • Chronic  

By Distribution Channel

  • Online Pharmacies
  • Offline Pharmacies

By Treatment

  • Anti-Viral Drugs
  • Vaccine
  • Immune Modulator Drugs

Global Hepatitis B Virus Market Report Segment by Region

North America

  • US
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa


To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/hepatitis-b-virus-market